Publicaciones en las que colabora con Begoña López Salazar (23)

2021

  1. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches

    Nature Reviews Cardiology, Vol. 18, Núm. 7, pp. 479-498

2019

  1. Association of left atrium voltage amplitude and distribution with the risk of atrial fibrillation recurrence and evolution after pulmonary vein isolation: An ultrahigh-density mapping study

    Journal of Cardiovascular Electrophysiology, Vol. 30, Núm. 8, pp. 1231-1240

  2. Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation

    Journal of the American College of Cardiology, Vol. 73, Núm. 12, pp. 1398-1410

2017

  1. Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites

    Scientific Reports, Vol. 7

2014

  1. Epicardial delivery of collagen patches with adipose-derived stem cells in rat and minipig models of chronic myocardial infarction

    Biomaterials, Vol. 35, Núm. 1, pp. 143-151

2013

  1. A synthetic peptide from transforming growth factor-β1 Type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats

    Antioxidants and Redox Signaling, Vol. 19, Núm. 14, pp. 1607-1618

  2. Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients

    Journal of Hypertension, Vol. 31, Núm. 3, pp. 587-594

  3. Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis

    Clinical Science, Vol. 125, Núm. 6, pp. 291-300

2012

  1. Blockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats

    Oxidative Medicine and Cellular Longevity

2011

  1. Association of the peroxisome proliferator-activated receptor α gene L162V polymorphism with stage C heart failure

    Journal of Hypertension, Vol. 29, Núm. 5, pp. 876-883

2008

  1. Response to association of increased plasma cardiotrophin-1 with left ventricular mass indexes in normotensive morbid obesity [4]

    Hypertension

2005

  1. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?

    Journal of Hypertension, Vol. 23, Núm. 3, pp. 625-632

  2. Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients

    Journal of Hypertension, Vol. 23, Núm. 12, pp. 2297-2304

2003

  1. The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives

    Journal of Hypertension, Vol. 21, Núm. 11, pp. 2085-2092

2001

  1. Biochemical assessment of myocardial fibrosis in hypertensive heart disease

    Hypertension

  2. Marcadores bioquímicos de fibrosis miocárdica en las enfermedades cardíacas

    Hipertensión y Riesgo Vascular, Vol. 18, Núm. 8, pp. 383-388

  3. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients

    Circulation, Vol. 104, Núm. 3, pp. 286-291

  4. Vascular oxidative stress and endothelial dysfunction

    Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 21 Suppl 1, pp. 61-66

2000

  1. Chronic AT1 blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats

    Hypertension, Vol. 35, Núm. 6, pp. 1197-1202

  2. Diagnóstico bioquímico de la fibrosis miocárdica hipertensiva

    Revista Espanola de Cardiologia, Vol. 53, Núm. SUPPL. 1, pp. 8-13